Roots’ RZTO cooling technology doubles cannabis yield in high-tech greenhouse

|

Published 16-OCT-2019 11:08 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Roots Sustainable Agricultural Technologies Limited (ASX:ROO) today announced that its upgraded Root Zone Temperature Optimisation (RZTO) cooling system has been shown to more than double the dry flower yield in some strains of greenhouse-grown cannabis in Southern California.

Roots’ RZTO cooling system increased the yield of dry cannabis flowers by up to 118 per cent compared to uncooled crops from various strains within a climate-controlled greenhouse at Canndescent’s facilities in Southern California.

Following an initial sale of the technology to Canndescent in May 2019, Roots’ RZTO cooling system was installed by early June in a greenhouse at Canndescent’s facilities.

Canndescent has risen quickly in the three years since it was established to become the number one selling, top shelf cannabis flower in California.

Roots’ upgraded Root Zone Temperature Optimisation (RZTO) cooling system was used to stabilise the roots of cannabis plants at an optimal temperature of 21 degrees Celsius (70°F), despite ambient air temperatures within the greenhouse reaching 30°C (85°F) and outside temperatures topping 43°C (120°F).

Increases of 30 and 118 per cent were achieved during the US summer on two cannabis strains of 400 and 200 cooled plants respectively within a climate-controlled greenhouse utilising wet mattresses and fans. These results follow an initial sale to premium cannabis producer Canndescent in May with the installation completed in early June 2019.

Today’s results should translate to an immediate return on Canndescent’s investment in Roots’ RZTO cooling technology, and for Roots the results demonstrate the effectiveness of its technology in such conditions.

Roots' CEO, Dr Sharon Devir said, “These impressive results demonstrate the effectiveness of our root zone cooling technology when used in conjunction with traditional air-cooling systems. Southern California’s dry desert climate varies considerably during the summer months, with temperatures fluctuating between 20 and 40 degrees Celsius. Extreme heat has a detrimental impact on cannabis production and crop quality.

“These results verify the effectiveness of our root zone technology on greenhouse-grown cannabis, more than doubling dry flower yield in certain strains to quickly generate a return on investment for growers while also lowering energy costs associated with traditional heating and cooling systems.

“The results also reinforce the uniqueness of our offering within the highly competitive cannabis market and are consistent with those achieved by cannabis growers in both North America and Israel.”

Daniel McClure, Canndescent’s VP Agronomist, added, “Roots’ RZTO technology complemented our existing cooling methods to significantly increase the yield of our unique cannabis strains. In addition to increased yield, Roots’ technology also increased the quality of the crops.”



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X